Site menu
Menu
Looking to broaden your horizons, diversify your portfolio and invest in the mighty US stock market? Here are the latest US stock ideas, stories and news from our team at Rask Media, covering companies on the two largest stock exchanges in the world: the New York Stock Exchange (NYSE) and the NASDAQ.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.19% to 6856.90.
The Australian stock market has given up all of the gains that it had made in 2023, with the benchmark S&P/ASX 200 (INDEXASX: XJO) losing 56.6 points, or 0.8%, on Monday to 6,844.1, with resources weakness the major culprit. That puts the index in the red by 2.8% for the year.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.82% to 6844.10.
CSL Limited (ASX: CSL) is currently trading at a 1-yr forward PE of 24x, a 40% premium to the ASX Industrials. 24x puts it on the same multiple as defensives like Woolworths Group Ltd (ASX: WOW), Wesfarmers Ltd (ASX: WES) and Sonic Healthcare Ltd (ASX: SHL), for ~2-3x the earnings growth!
The local share market posted a negative end to the week, with both the S&P/ASX200 (INDEXASX: XJO) and All Ordinaries (INDEXASX: XAO) share prices falling 1.2% on Friday, dragging the benchmarks 2.1% lower for the week.
Will Ozempic sink ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL)? Will Tesla’s Cyber Truck come to Australia? The Australian Investors Podcast explains…
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.16% to 6900.70.
The wall of worry continues to pressure the Australian share market with the escalating conflict sending both the S&P/ASX200 (INDEXASX: XJO) and All Ordinaries (INDEXASX: XAO) more than 1% on Thursday.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.36% to 6981.60.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.19% to 6856.90.
The Australian stock market has given up all of the gains that it had made in 2023, with the benchmark S&P/ASX 200 (INDEXASX: XJO) losing 56.6 points, or 0.8%, on Monday to 6,844.1, with resources weakness the major culprit. That puts the index in the red by 2.8% for the year.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.82% to 6844.10.
CSL Limited (ASX: CSL) is currently trading at a 1-yr forward PE of 24x, a 40% premium to the ASX Industrials. 24x puts it on the same multiple as defensives like Woolworths Group Ltd (ASX: WOW), Wesfarmers Ltd (ASX: WES) and Sonic Healthcare Ltd (ASX: SHL), for ~2-3x the earnings growth!
The local share market posted a negative end to the week, with both the S&P/ASX200 (INDEXASX: XJO) and All Ordinaries (INDEXASX: XAO) share prices falling 1.2% on Friday, dragging the benchmarks 2.1% lower for the week.
Will Ozempic sink ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL)? Will Tesla’s Cyber Truck come to Australia? The Australian Investors Podcast explains…
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.16% to 6900.70.
The wall of worry continues to pressure the Australian share market with the escalating conflict sending both the S&P/ASX200 (INDEXASX: XJO) and All Ordinaries (INDEXASX: XAO) more than 1% on Thursday.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.36% to 6981.60.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024
